Company / CapEx per Share
Pfizer CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.46
FY2025
5-year range
$0.36 / $0.51
FY2021-FY2025
Trend
-9.2%
vs FY2024
Sector context
#28 of 192
Health Care
What the data says
Pfizer's capex per share of $0.46 is higher than 85% of companies in the Health Care sector (FY2025). CapEx per Share has fluctuated over the past 10 years, ranging from $0.19 in FY2016 to $0.51 in FY2024.
Based on SEC 10-K filings.
0.46 in FY2025 with a 5-year CAGR of +4.3%. Top quartile in the Health Care sector.
Declined from $0.47 to $0.46 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +5.2%
- 5-Year CAGR
- +4.3%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 192This company $0.46 Sector average $3.54
▼
-87.0% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 9.2% year-over-year.
- Ranks #28 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.46 | -9.2% |
| FY2024 | $0.51 | +6.8% |
| FY2023 | $0.47 | +20.2% |
| FY2022 | $0.40 | +9.6% |
| FY2021 | $0.36 | -3.2% |
| FY2020 | $0.37 | +10.3% |
| FY2019 | $0.34 | +14.1% |
| FY2018 | $0.30 | +32.6% |
| FY2017 | $0.22 | +19.6% |
| FY2016 | $0.19 | -7.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026